DANA, Nasim; VASEGHI, Golnaz; HAGHJOOY JAVANMARD, Shaghayegh. PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling. Journal of Pharmacy & Pharmaceutical Sciences, [S. l.], v. 22, n. 1, p. 418–423, 2019. DOI: 10.18433/jpps30626. Disponível em: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/30626. Acesso em: 25 nov. 2024.